Global Baby Foods and Infant Formula Market Analysis and Insights

The global Baby Foods and Infant Formula market estimated at US$69.5 billion in the year 2024 is projected to grow at a CAGR of 6.89% and reach US$103.7 billion by 2030. The growth in the market is driven by the increasing awareness about infant nutrition and its importance, higher disposable incomes, and accelerating urbanization. Dual-income households and time-pressed caregivers are trading up from homemade purées to

convenient, nutritionally complete options, while premiumization (organic, clean-label, grass-fed, non-GMO) lifts average selling prices. Regulatory tightening after safety incidents has also nudged buyers toward trusted brands with verified traceability, elevating companies that invest in quality systems, clinically supported ingredients, and transparent sourcing.

Product innovation is a second engine of growth. Clinically validated additions—HMOs, DHA/ARA, probiotics/postbiotics, lactoferrin, choline, and gentle proteins—are differentiating formulas and commanding price premiums. Adjacent needs are expanding the pie: hypoallergenic and specialty formulas (for CMPA, reflux, premature infants), goat and A2 protein bases, plant-based alternatives for flexitarian households, and culturally tailored flavors/fortifications. In baby foods, texture-stage portfolios, snackable formats, pouches with hidden veggies, iron-rich cereals, and sugar- and salt-management address both nutrition and convenience.

Looking forward, the biggest opportunities lie in emerging markets with improving cold chains and modern retail, digital distribution—D2C subscriptions, tele-lactation support, and data-driven replenishment to boost retention, local manufacturing/contract partnerships to navigate import barriers and origin rules, and sustainability levers: recyclable pouches, lower-carbon dairy, regenerative supply, and verified deforestation-free fats. Companies that pair medical-marketing (HCP education, clinical dossiers) with caregiver communities, invest in rapid compliance to evolving marketing codes, and build resilient supply (whey, specialty lipids, HMOs) are positioned to capture share and margin as the category matures.

Baby Foods and Infant Formula Market Regional Insights

The North American baby foods and infant formula market is expected to grow significantly during the forecast period. The regional market is propelled by rising parental focus on health and nutrition, demand for organic and clean-label products, and the convenience needs of busy lifestyles. United States contributed around 81% of the total North American baby foods and infant formula market is estimated to have a market value of US$19.1 billion in the year 2024. Among the other noteworthy geographic markets are Canada and Mexico, each forecast to grow at 4.78% and 3.93% respectively over the 2025-2030 period.

The APAC baby foods and infant formula market is experiencing rapid growth, driven by rapid urbanization, rising middle-class incomes, increasing birth rates in emerging economies, and growing awareness of infant nutrition. China is expected to dominate the Asia-Pacific market and reach a market size of US$26.1 billion by 2030.

Within Europe, Germany, the U.K., France, Italy and Spain are the key countries responsible for the significant growth of the regional market. Germany is expected to grow at a CAGR of 5.12% over the forecast period.

Meanwhile, the Middle East & Africa is expected to show limited growth due to the strong presence of under-developed countries in Africa who are still struggling to meet technology standards. However, any growth that the region experiences is expected to come from developing Middle Eastern nations such as Qatar, U.A.E, and Oman due to a similar growth pattern as the Asia Pacific.

Key Players

Key players profiled in the report include Abbott Laboratories; Arla Foods amba; Beingmate Group; Bellamy’s Organic; Biostime Inc.; Dana Dairy Group; Danone S.A.; Feihe International, Inc.; Fonterra Co-operative Group; GCMMF; Hain Celestial Group, Inc.; Hero Group; HiPP UK Ltd.; Meiji Holdings Co., Ltd.; Morinaga Milk Industry Co. Ltd.; Nestlé S.A.; Perrigo Company plc; Reckitt Benckiser Group plc (Mead Johnson Nutrition); Royal FrieslandCampina N.V.; Synlait Ltd.; The a2 Milk Company; The Kraft Heinz Company; Wakodo Co. Ltd.; Yashili Group Co., Ltd.; Yili Group, among others.

Competitive Landscape

September 01, 2025 – Following its announcement on 18 August 2025, The a2 Milk Company confirmed that it has completed the acquisition of an integrated nutritional manufacturing facility with two China label infant milk formula product registrations, located in Pokeno, New Zealand. The Pokeno facility is world-class with a proven track record of producing high-quality infant milk formula.

July 10, 2025 – The Kraft Heinz Company announced that it has entered into an agreement to sell its infant and specialty food business in Italy to NewPrinces S.p.A., one of the country’s leading food and beverage producers.The proposed transaction is expected to close at the end of 2025, subject to regulatory review and approval.

Baby Food And Infant Formula Market Segmentation 

• By Product Type
  • Milk Formula
  • Dried Baby Foods
  • Prepared Baby Foods
  • Others

• By Distribution Channels
  • Online
  • Offline

• By region
  • North America
  • South America
  • Europe
  • Asia Pacific
  • Middle East and Africa

The research report titled Baby Food And Infant Formula market  provides a comprehensive review of market trends, market growth drivers, PEST Analysis, Market growth inhibitors, and strategic industry activities and SWOT Analysis of key players in the market.

The report provides market estimates and forecast for geographic markets such as the North America (US, Canada, Mexico and Rest of North America), South America (Brazil, Argentina and Rest of South America), Europe (Germany, France, U.K., Russia, Italy, Spain, Sweden, Netherlands, Poland, Austria, Norway, Switzerland, Denmark and Rest of Europe), Asia-Pacific (China, Japan, South Korea, Taiwan, India, Australia and Rest of Asia-Pacific), Middle East (Iran, Turkey, Kuwait, UAE, Israel and Rest of Middle East) & Africa.